Pfizer Inc (NYSE:PFE)

33.30
Delayed Data
As of 4:00pm ET
 -0.60 / -1.77%
Today’s Change
31.77
Today|||52-Week Range
54.93
-35.01%
Year-to-Date
Market Today: Walmart's Shift in Shopper Behavior, COVID-19 Vaccine Updates, and NextEra ...
3:30pm / GuruFocus News - Paid Partner Content
Where Will Pfizer Be in 5 Years?
Sep 29 / MotleyFool.com - Paid Partner Content
Novavax (NVAX) Up 8% on FDA Nod for Updated COVID Booster Jab
11:19am / Zacks.com - Paid Partner Content
Is it Time to Buy Pfizer, Moderna, or AstraZeneca's Stock?
Sep 28 / Zacks.com - Paid Partner Content
2 High-Yield Dividend Stocks to Buy in October
11:00am / MotleyFool.com - Paid Partner Content
2 Undervalued High-Yield Names for High Total Returns
Sep 28 / GuruFocus News - Paid Partner Content
2 Magnificent Growth Stocks to Buy Right Now
9:25am / MotleyFool.com - Paid Partner Content
Undervalued Biotech Stocks Shine: Pfizer and BioNTech Show Robust Resilience
Sep 28 / GuruFocus News - Paid Partner Content
Pfizer (PFE) Stock Moves -0.12%: What You Should Know
Oct 03 / Zacks.com - Paid Partner Content
Undervalued Biotech Stocks Shine: Pfizer and BioNTech Show Resilience
Sep 28 / GuruFocus News - Paid Partner Content
Kinnate Biopharma (KNTE) Falls 40% in a Month: Here's Why
Oct 03 / Zacks.com - Paid Partner Content
Why Ginkgo Bioworks Stock Is Surging Higher Today
Sep 27 / MotleyFool.com - Paid Partner Content
Cathie Wood Is Buying This Growth Stock Hand Over Fist Lately. Should You Follow Her Lead?
Oct 03 / MotleyFool.com - Paid Partner Content
These 2 Stocks Are Getting Smart Investors' Attention Wednesday
Sep 27 / MotleyFool.com - Paid Partner Content
Is Pfizer Stock a Buy Now?
Oct 03 / MotleyFool.com - Paid Partner Content
Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock
Sep 27 / Zacks.com - Paid Partner Content
Unveiling Pfizer (PFE)'s Value: Is It Really Priced Right? A Comprehensive Guide
Oct 02 / GuruFocus News - Paid Partner Content
2 Magnificent Growth Stocks to Buy On the Dip
Sep 27 / MotleyFool.com - Paid Partner Content
3 Top Stocks to Buy in October and Hold Forever
Oct 02 / MotleyFool.com - Paid Partner Content
FDA Accepts Sanofi's (SNY) sBLA for Dupixent in Pediatric EoE
Sep 26 / Zacks.com - Paid Partner Content
Baudax's (BXRX) Hemophilia A Drug Gets FDA's Orphan Drug Tag
Oct 02 / Zacks.com - Paid Partner Content
Pfizer (PFE) Outpaces Stock Market Gains: What You Should Know
Sep 25 / Zacks.com - Paid Partner Content
ACM Research and Advance Auto Parts have been highlighted as Zacks Bull and Bear of the Day
Oct 02 / Zacks.com - Paid Partner Content
CDC Recommends Pfizer's (PFE) RSV Jab to Protect Newborns
Sep 25 / Zacks.com - Paid Partner Content
3 Stocks to Buy in October That Could Soar More Than 40% Over the Next 12 Months, According to Wall Street
Oct 01 / MotleyFool.com - Paid Partner Content
The Zacks Analyst Blog Highlights Pfizer, Merck and AstraZeneca
Sep 25 / Zacks.com - Paid Partner Content
Moderna's Shares Could Take Off if These 2 Things Happen
Sep 30 / MotleyFool.com - Paid Partner Content
Pharma Stock Roundup: EU Nod to PFE's Litfulo, FDA Priority Tag to MRK Applications
Sep 22 / Zacks.com - Paid Partner Content
Why Pfizer and BioNTech Stocks Zoomed Higher Today
Sep 29 / MotleyFool.com - Paid Partner Content
3 Bargain Stocks to Buy in a Market That's Priced for Perfection
Sep 21 / MotleyFool.com - Paid Partner Content
Unveiling Pfizer (PFE)'s Value: Is It Really Priced Right? A Comprehensive Guide
Sep 29 / GuruFocus News - Paid Partner Content
2 Dividend Growth Stocks to Buy Right Now
Sep 21 / MotleyFool.com - Paid Partner Content
3 Stocks to Focus on as Demand for Obesity Drugs Booms
Sep 29 / Zacks.com - Paid Partner Content
With New COVID-19 Boosters in Tow, Which Is the Better Buy: Pfizer, BioNtech, or Moderna Stock?
Sep 20 / MotleyFool.com - Paid Partner Content